TTrialPathMatch Me to Trials
← Back to trials
RecruitingSARS- CoV-2Cardiovascular DiseasesChronic Kidney Diseases

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.

Sponsor: University of South Carolina

You may qualify if…

  • COVID-19 survivor inclusion criteria
  • African American
  • Male and female
  • Living in a Medically Underserved Area and/or a designated rural area of South Carolina
  • ≥ 18 years and above
  • A history of a COVID-19-associated hospitalization, ER or Urgent Care visit since March 11th, 2020
  • A previous diagnosis of one or more of the following conditions: type 2 diabetes, hypertension, cardiovascular disease, chronic kidney disease, or stroke (\>3 months)
  • Carepartner inclusion criteria

You may not qualify if…

  • Survivor and Carepartner exclusion criteria • Enrolled in related clinical trials

Where it's recruiting

Source: ClinicalTrials.gov · NCT05370014 · last updated 2025-05-16